General
New test could flag which men need aggressive prostate cancer treatment and which don't
Fox News
•
October 26, 2026
•
1 min read
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.
This is a developing story that hasn’t been grouped with other coverage yet. Check back soon for cross‑perspective analysis.
1
Articles
1
Sources
0
Fact-Checks
Read this story on the original source
Fox News
(Right)
"New test could flag which men need aggressive prostate cancer treatment and which don't"
Latest Stories
The New York Times
Justice Dept. Brings More Charges Against Comey, Accusing Him of Leaks
32m ago
TMZ
Nick Carter Sexual Assault Battle: Witnesses Refute Accuser's Claims Against Pop Star
42m ago
The New York Times
Brazil’s Vote Is a Victory for the Amazon, Environmentalists Say
44m ago
TMZ
Jason Oppenheim Offers Support to Ex Chrishell Stause After G-Flip Breakup
47m ago
Discover More in Politics
Fox News
Robert Griffin III says he would '100%' take Baylor's vacant head football coach job
59m ago
Fox News
Oregon Ducks' collapse continues, as loss to Illinois puts Dan Lanning on the hot seat in Eugene
1h ago
Fox News
DOJ seeks to prosecute Comey over alleged national defense disclosure
1h ago
More from Fox News
Related Topics
Claim Verification
We did not find any verified fact‑checks for this article. Our system continuously scans multiple fact‑checking organizations. If you believe a claim needs verification, you can submit it via our contact page.
Media Literacy Tip: "Cross-reference sensational headlines with multiple reputable sources before sharing or accepting them as fact."